P3 Health Partners (PIII) Earnings Analysis

P3 Health Partners (PIII) next reports earnings on 2026-08-10, consensus EPS -1.895 USD. Last quarter (2026-05-14) it beat with EPS 0.32 USD vs -4.85 USD est (+106.6%). It has beaten estimates in 1/5 recent quarters (20%). Trailing P/E -0.26.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does PIII next report earnings?

Next earnings date2026-08-10
Consensus EPS estimate-1.895 USD
Revenue estimate0.38B

PIII earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-140.32 USD-4.85 USD+106.6%Beat
2026-03-26-23.02 USD-8.06333 USD-185.5%Miss
2025-11-14-9.67 USD-5.2925 USD-82.7%Miss
2025-08-14-6.23 USD-3.29 USD-89.4%Miss
2025-05-15-6.28 USD-5 USD-25.6%Miss

Beat rate: 1/5 (20%) over reported quarters with consensus data.

PIII valuation and analyst view

Trailing P/E-0.26
Trailing EPS-38.39568 USD
Price / book-0.23
Dividend yield0.00%
Market cap0.03B
Analyst consensusBuy (2 buy / 2 hold / 0 sell)
Avg price target14 USD

Related research pages

Frequently asked questions

When is P3 Health Partners (PIII)'s next earnings date?

P3 Health Partners is next scheduled to report on 2026-08-10, with a consensus EPS estimate of -1.895 USD and revenue estimate of 0.38B.

Did PIII beat earnings last quarter?

In its 2026-05-14 report, PIII posted EPS of 0.32 USD versus a -4.85 USD estimate — a beat of 106.6%.

What is PIII's earnings track record?

Over the last 5 reported quarters with consensus data, PIII beat estimates 1 times (20%).

What is PIII's current P/E ratio and EPS?

PIII trades at a trailing P/E of -0.26 on trailing EPS of -38.39568126520681 USD.

What do analysts rate PIII?

Analyst consensus is "Buy" across 4 ratings (0 strong buy, 2 buy, 2 hold, 0 sell, 0 strong sell). Average 12-month price target: 14 USD.